Navi Mumbai hill quarry blasts endanger Tata cancer hospital
The tehsildar has confirmed the quarry's lack of proper authorisation.
The unlawful quarrying activities near Tata Cancer Hospital at Kharghar Hills, reportedly run by politicians and quarry operators, have resulted in damage to the hospital's buildings. These operations pose risks to patients and valuable medical equipment.
The ACTREC director, Dr Pankaj Chaturvedi, in his letter to the CM stated, "It's the health of the patients that is more important and which is invisible and non-negotiable.
The northwest hill near our cancer treatment facility has been severely impacted, with multiple pits excavated and green cover obliterated."
You Can Also Check:
Mumbai AQI
|
Weather in Mumbai
|
Bank Holidays in Mumbai
|
Public Holidays in Mumbai
The continuous blasting and drilling operations produce excessive noise and dust pollution, jeopardising patient wellbeing and environmental health. Dr Chaturvedi has sought immediate governmental action to halt these "destructive" quarrying activities and explore sustainable alternatives.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
This Could Be the Best Time to Trade Gold in 5 Years
IC Markets
Learn More
Undo
He stressed the necessity of safeguarding cancer patients' health and welfare, protecting biodiversity, and maintaining eco-sensitive areas.
An RTI query by Mumbai-based NGO NatConnect Foundation revealed that the quarry was operating without government approval. NatConnect director, B N Kumar, brought the matter to the chief minister's attention, who referred it to Raigad's district collector.
Following a 2018 NGT ruling regarding Parsik Hill quarrying, environmental clearance is required for such operations.
Dr Chaturvedi informed the CM about structural damage to 25-year-old hospital buildings, including cracked beams and slabs, weakening ACTREC campus structures.
The deterioration has led to water infiltration during rains, causing fungal growth in cleanroom facilities and increasing patient risks. Dr Chaturvedi highlighted serious concerns about rising noise and dust pollution from uncontrolled quarrying adjacent to ACTREC.
These ongoing activities have virtually destroyed a previously verdant hill.
The dust affects residential sectors 22, 30, and 35, contaminating the hospital's sterile treatment areas. This creates considerable risks for vulnerable patients receiving crucial treatments like bone marrow transplants and proton therapy. Equipment requiring sterile environments faces persistent contamination risks.
Dr Chaturvedi pointed out the quarrying operations' proximity to Pandavkada Waterfalls, an eco-tourism site, and the upcoming Kharghar-Turbhe tunnel. Jyoti Nadkarni from the Kharghar Hill and Wetlands forum noted regular observations of dump trucks transporting stones from the quarry area.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
2 hours ago
- Economic Times
Cheaper cancer care therapy earns big bucks for pharma company
India's cell and gene therapy pioneer ImmunoAct has turned profitable in its first full year of operations, a rare feat in the country's emerging startup landscape where research-based pharma enterprises encounter serious scale and cash flow challenges. ImmunoACT, in which Hyderabad-based drugmaker Laurus Labs has roughly 34% equity stake, saw revenues of ₹62 crore with a profit before tax of ₹12 crore in FY25, according to sources. The year before, ImmunoAct had revenues of ₹11 crore. Founded by immunologist Rahul Purwar in 2013, ImmunoACT was spun off from the department of bioengineering department of IIT Bombay in 2018. ImmunoACT's NexCAR19 is the first indigenously developed breakthrough cancer CAR-T (chimeric antigen receptor T-cell) therapy approved by India's central drug regulatory agency in October 2023. NexCAR19 was formally launched in India in April 2024 at a price ~90% cheaper than its US and European counterparts like Novartis and Gilead, making it far more affordable for India and low-and-middle income countries, on its potential approval. So far, the therapy has been infused in over 350 patients across 70 hospitals in India. In CAR-T treatment, the patient's immune cells are extracted and through a maze of re-engineering processes infused back to recognize and kill cancer cells, giving a longer remission to patients as compared to the conventional options like immunotherapy or bone marrow transplants. The therapy is used when all other options are CAR-T dose (one-and-done infusion) costs around ₹30 lakh, which was initially priced at ₹42 lakh, and is expected to see a further decline as demand picks ImmunoACT has recently appointed former managing director of Roche India V Simpson Immanuel as its strategic Purwar added, "We needed someone who understands not just the commercial landscape, but also the nuances of innovation, patient access, and global expansion." Earlier this year, Immuneel Therapeutics, backed by leading names like Kiran Mazumdar-Shaw and globally renowned oncologist Siddhartha Mukherjee secured approval for Qartemi, its cell therapy for adult B-cell non-Hodgkin Lymphoma, in India. Companies like Cipla, Dr Reddy's Labs and Bharat Biotech are investing heavily in new CAR-Ts. Globally, CAR-Ts are at the frontiers of a range of cancer treatments, attracting billions of dollars in investments from large drugmakers. The market for such therapies is expected to touch $134 billion by 2034 from around $10 billion at present.
Time of India
2 hours ago
- Time of India
Furnish data on malnutrition in 4 weeks: HC tells MP govt
Bhopal: A division bench of the Madhya Pradesh High Court asked district collectors from across the state to file a status report on the malnutrition situation in their respective districts. The bench, comprising Chief Justice Sanjeev Sachdeva and Justice Vinay Saraf, gave four weeks for this purpose and issued notices to the state govt and the chief secretary in response to a Public Interest Litigation (PIL) moved by a resident of Jabalpur, Deepankar Singh. Singh, in his petition, said that there is an alarming situation in MP regarding malnutrition among its people, but the state govt keeps hiding this terrible state of affairs by 'manipulating' data. He requested the court to ask for a report on malnutrition from the state govt to know the actual state of malnutrition prevalent among the people in MP so that efforts could be made to tackle the menace of malnutrition, particularly among the children. He said that according to the Poshan Tracker-2.0 and National Health Survey report, MP stands second in the country in terms of malnutrition. Attributing this situation to poor implementation of schemes on health and nutrition, he said that weak, underweight, and stunted children are born in the state because of malnutrition. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You will never turn off your computer again. Undo He further said that CAG, in its report, referred to a massive scam in the transportation and quality of nutritious food, but there was no action on the part of the state govt. The petitioner said that among 66 lakh children in the age group of 0 to 6 years, 10 lakh are malnourished, and 1.36 lakh of them are severely malnourished. The prevalence of anaemia among women is 57%. It was also pointed out during the hearing that Rs 1.80 crore were paid as rent for anganwadi centres in Jabalpur district alone, but only a handful of children visit those centres. After the initial hearing, the court asked all the district collectors from across the state to furnish a report on the status of malnutrition in their respective districts within four weeks. Advocate Amit Singh Sengar and Atul Jain appeared in the case for the petitioner.
Time of India
3 hours ago
- Time of India
AI crash: Mum's skin grafts help heal infant's 36% burns
Eight-month-old Dhyaansh is all smiles today, his rosy cheeks glowing as he grins widely. After receiving skin grafts on his face, head and hands from his mother, Manisha, 30, the infant has recovered from what could have been fatal injuries. The son and wife of Dr Kapil Kachhadiya, a urology resident at Civil Hospital, were recently discharged from a city hospital after five weeks of treatment for severe burns they suffered in the aftermath of the AI 171 airplane crash on June 12. The mother-son duo was in the BJ Medical College hostel and residential quarters in Meghaninagar when the tragedy unfolded. Everything went black for a moment and then heat engulfed their residence. Manisha grabbed Dhyaansh and ran from the building through thick smoke and flames that made it nearly impossible for her to see anything. The hot air left the mother and child with serious burns. "There was a moment I thought we would not make it out. But I had to, for my child. We have both been through pain I cannot put into words," Manisha said. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad While Manisha suffered 25% burns, affecting her hands and face, eight-month-old Dhyaansh's condition was worse with 36% burns on his face, both arms, abdomen and chest. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo The duo was shifted to KD Hospital for treatment where Dhyaansh was immediately admitted to the pediatric intensive care unit (PICU). He needed a ventilator to breathe, fluid resuscitation, blood transfusion care and specialised treatment for burns. Dr Adit Desai, managing director of KD Hospital, said the case moved everyone involved. "It was deeply touching because of the mother's instinctive courage to save her child. From a medical standpoint, every department came together to ensure the best possible outcome."Dr Desai added that the hospital provided free treatment to six patients who were affected by the AI 171 airplane crash. Dr Rutvij Parikh, plastic surgeon at KD Hospital, said that the child's own skin and mother's skin grafts were used to treat the burn wounds. "The patient's age was a major factor. We had to make sure the wounds did not get infected and that his growth would be normal. The recovery of the child and mother has been satisfactory." "Dr Kapil's involvement as a father helped enormously. As a medical professional himself, he often made sure the dressings were done properly, even in the middle of the night," he added. The treatment involved several specialists: Dr Snehal Patel, neonatologist and pediatrician; Dr Tushar Patel, pulmonologist and critical care specialist; and Dr Mansi Dandnaik, critical care and transplant intensivist. Dr Snehal Patel described a serious complication that Dhyaansh faced. "Due to the incident, blood rushed into one side of the child's lungs. He was kept on ventilatory support, and an intercostal drainage tube was inserted until we achieved good lung expansion."
